CSPCY
Price
$4.12
Change
+$0.18 (+4.57%)
Updated
Jul 3 closing price
Capitalization
9.91B
GIFLF
Price
$11.45
Change
-$0.85 (-6.91%)
Updated
Jun 23 closing price
Capitalization
8.78B
Interact to see
Advertisement

CSPCY vs GIFLF

Header iconCSPCY vs GIFLF Comparison
Open Charts CSPCY vs GIFLFBanner chart's image
CSPC Pharmaceuticals Group
Price$4.12
Change+$0.18 (+4.57%)
Volume$21.94K
Capitalization9.91B
Grifols Sa
Price$11.45
Change-$0.85 (-6.91%)
Volume$1.22K
Capitalization8.78B
CSPCY vs GIFLF Comparison Chart in %
Loading...
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPCY vs. GIFLF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPCY is a Hold and GIFLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CSPCY: $4.12 vs. GIFLF: $11.45)
Brand notoriety: CSPCY and GIFLF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CSPCY: 739% vs. GIFLF: 95%
Market capitalization -- CSPCY: $9.91B vs. GIFLF: $8.78B
CSPCY [@Pharmaceuticals: Major] is valued at $9.91B. GIFLF’s [@Pharmaceuticals: Major] market capitalization is $8.78B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPCY’s FA Score shows that 2 FA rating(s) are green whileGIFLF’s FA Score has 1 green FA rating(s).

  • CSPCY’s FA Score: 2 green, 3 red.
  • GIFLF’s FA Score: 1 green, 4 red.
According to our system of comparison, CSPCY is a better buy in the long-term than GIFLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPCY’s TA Score shows that 3 TA indicator(s) are bullish while GIFLF’s TA Score has 4 bullish TA indicator(s).

  • CSPCY’s TA Score: 3 bullish, 5 bearish.
  • GIFLF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GIFLF is a better buy in the short-term than CSPCY.

Price Growth

CSPCY (@Pharmaceuticals: Major) experienced а +2.50% price change this week, while GIFLF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPCY($9.91B) has a higher market cap than GIFLF($8.79B). GIFLF has higher P/E ratio than CSPCY: GIFLF (62.50) vs CSPCY (11.34). CSPCY YTD gains are higher at: 76.977 vs. GIFLF (19.895). CSPCY has higher annual earnings (EBITDA): 7.63B vs. GIFLF (726M). CSPCY has higher revenues than GIFLF: CSPCY (31.1B) vs GIFLF (6.46B).
CSPCYGIFLFCSPCY / GIFLF
Capitalization9.91B8.79B113%
EBITDA7.63B726M1,050%
Gain YTD76.97719.895387%
P/E Ratio11.3462.5018%
Revenue31.1B6.46B481%
Total CashN/A557M-
Total DebtN/A10.9B-
FUNDAMENTALS RATINGS
CSPCY vs GIFLF: Fundamental Ratings
CSPCY
GIFLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
4287
PRICE GROWTH RATING
1..100
3746
P/E GROWTH RATING
1..100
1397
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GIFLF's Valuation (19) in the null industry is in the same range as CSPCY (21). This means that GIFLF’s stock grew similarly to CSPCY’s over the last 12 months.

CSPCY's Profit vs Risk Rating (82) in the null industry is in the same range as GIFLF (100). This means that CSPCY’s stock grew similarly to GIFLF’s over the last 12 months.

CSPCY's SMR Rating (42) in the null industry is somewhat better than the same rating for GIFLF (87). This means that CSPCY’s stock grew somewhat faster than GIFLF’s over the last 12 months.

CSPCY's Price Growth Rating (37) in the null industry is in the same range as GIFLF (46). This means that CSPCY’s stock grew similarly to GIFLF’s over the last 12 months.

CSPCY's P/E Growth Rating (13) in the null industry is significantly better than the same rating for GIFLF (97). This means that CSPCY’s stock grew significantly faster than GIFLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSPCYGIFLF
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
49%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
41%
Advances
ODDS (%)
Bullish Trend 3 days ago
68%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWB343.732.76
+0.81%
iShares Russell 1000 ETF
WDNA14.040.09
+0.63%
WisdomTree BioRevolution ETF
XMLV62.640.30
+0.48%
Invesco S&P MidCap Low Volatility ETF
DXD23.48-0.31
-1.30%
ProShares UltraShort Dow30
SDOW39.52-0.84
-2.08%
ProShares UltraPro Short Dow30

CSPCY and

Correlation & Price change

A.I.dvisor tells us that CSPCY and CHJTF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSPCY and CHJTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPCY
1D Price
Change %
CSPCY100%
+4.50%
CHJTF - CSPCY
23%
Poorly correlated
N/A
BAYRY - CSPCY
20%
Poorly correlated
-1.16%
OPHLY - CSPCY
20%
Poorly correlated
-0.85%
DSNKY - CSPCY
16%
Poorly correlated
-2.41%
BAYZF - CSPCY
13%
Poorly correlated
-0.90%
More

GIFLF and

Correlation & Price change

A.I.dvisor tells us that GIFLF and GIFOF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIFLF and GIFOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFLF
1D Price
Change %
GIFLF100%
N/A
GIFOF - GIFLF
30%
Poorly correlated
N/A
BAYZF - GIFLF
10%
Poorly correlated
-0.90%
DSNKY - GIFLF
7%
Poorly correlated
-2.41%
CSPCY - GIFLF
7%
Poorly correlated
+4.50%
DSKYF - GIFLF
6%
Poorly correlated
-2.39%
More